I. PATIENT ASSESSMENT |
|
|
|
1 | (3) |
|
|
|
|
|
|
4 | (3) |
|
|
|
|
|
Measurement of Glomerular Filtration Rate |
|
|
7 | (4) |
|
|
|
|
|
Measurement of Urinary Protein |
|
|
11 | (3) |
|
|
|
|
|
|
14 | (6) |
|
|
|
|
|
|
|
|
|
|
20 | (3) |
|
|
|
|
|
|
23 | (2) |
|
|
|
|
|
Drug Therapy in Renal Disease |
|
|
25 | (4) |
|
|
|
|
II. CLINICAL SYNDROMES |
|
|
Etiology, Pathophysiology, and Diagnosis of Acute Renal Failure |
|
|
29 | (4) |
|
|
|
|
|
Management of Acute Renal Failure |
|
|
33 | (3) |
|
|
|
|
|
|
36 | (3) |
|
|
|
|
|
|
39 | (3) |
|
|
|
|
|
|
42 | (3) |
|
|
|
|
|
|
45 | (3) |
|
|
|
|
|
|
48 | (2) |
|
|
|
|
|
Rapidly Progressive Glomerulonephritis |
|
|
50 | (4) |
|
|
|
|
|
|
|
|
|
|
54 | (3) |
|
|
|
|
|
|
57 | (5) |
|
|
|
|
|
|
62 | (4) |
|
|
|
|
|
Disorders of Tubular Function |
|
|
66 | (3) |
|
|
|
|
III. PRIMARY GLOMERULAR DISEASE |
|
|
|
69 | (3) |
|
|
|
|
|
Focal Segmental Glomerulosclerosis |
|
|
72 | (3) |
|
|
|
|
|
|
|
|
|
Membranous Glomerulopathy |
|
|
75 | (5) |
|
|
|
|
|
|
80 | (2) |
|
|
|
|
|
Membranoproliferative Glomerulonephritis |
|
|
82 | (5) |
|
|
|
|
|
|
|
|
IV. SECONDARY GLOMERULAR DISEASE |
|
|
|
87 | (4) |
|
|
|
|
|
|
91 | (3) |
|
|
|
|
|
Postinfectious Glomerulonephritis |
|
|
94 | (3) |
|
|
|
|
|
Hepatitis-Associated Glomerulonephritis |
|
|
97 | (3) |
|
|
|
|
|
HIV-Associated Renal Disorders |
|
|
100 | (3) |
|
|
|
|
V. OTHER PARENCHYMAL RENAL DISEASES |
|
|
|
103 | (3) |
|
|
|
|
|
Cystic Diseases of the Kidneys |
|
|
106 | (5) |
|
|
|
|
|
|
|
|
|
Other Hereditary Renal Disease |
|
|
111 | (3) |
|
|
|
|
|
|
114 | (3) |
|
|
|
|
|
|
117 | (4) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Vascular Renal Disorders |
|
|
121 | (3) |
|
|
|
|
|
|
|
|
|
|
124 | (3) |
|
|
|
|
|
Renal Disease due to Dysproteinemias |
|
|
127 | (4) |
|
|
|
|
VI. END-STAGE RENAL DISEASE: CAUSES AND CONSEQUENCES |
|
|
Epidemiology and Outcomes of End-Stage Renal Disease |
|
|
131 | (2) |
|
|
|
|
|
|
133 | (3) |
|
|
|
|
|
|
136 | (2) |
|
|
|
|
|
Anemia Associated with Renal Failure |
|
|
138 | (2) |
|
|
|
|
|
Other Manifestations of Uremia |
|
|
140 | (3) |
|
|
|
|
VII. END-STAGE RENAL DISEASE: MANAGEMENT |
|
|
Technical Aspects of Hemodialysis |
|
|
143 | (3) |
|
|
|
|
|
Hemodialysis: Assessing Adequacy |
|
|
146 | (4) |
|
|
|
|
|
Complications of Hemodialysis |
|
|
150 | (3) |
|
|
|
|
|
Technical Aspects of Peritoneal Dialysis |
|
|
153 | (6) |
|
|
|
|
|
Complications of Peritoneal Dialysis |
|
|
159 | (5) |
|
|
|
|
|
Renal Transplantation: Epidemiology and Outcomes |
|
|
164 | (4) |
|
|
|
|
|
Renal Transplantation: Donor and Recipient Evaluation |
|
|
168 | (4) |
|
|
|
|
|
Renal Transplantation: Classification and Consequences of Rejection |
|
|
172 | (3) |
|
|
|
|
|
Renal Transplantation: Immunosuppression |
|
|
175 | (5) |
|
|
|
|
|
Complications of Renal Transplantation |
|
|
180 | (3) |
|
|
|
|
VIII. HYPERTENSION |
|
|
|
183 | (6) |
|
|
|
|
|
Renal Parenchymal Hypertension |
|
|
189 | (4) |
|
|
|
|
|
Renovascular Hypertension |
|
|
193 | (4) |
|
|
|
|
|
|
197 | (3) |
|
|
|
|
|
Other Causes of Secondary Hypertension |
|
|
200 | (3) |
|
|
|
|
|
|
203 | (4) |
|
|
|
|
|
|
207 | (4) |
|
|
|
|
IX. ACID-BASE AND ELECTROLYTE DISORDERS |
|
|
|
211 | (5) |
|
|
|
|
|
|
216 | (3) |
|
|
|
|
|
|
219 | (3) |
|
|
|
|
|
|
222 | (2) |
|
|
|
|
|
Hyponatremia and Hypernatremia |
|
|
224 | (4) |
|
|
|
|
|
Hypokalemia and Hyperkalemia |
|
|
228 | (3) |
|
|
|
|
|
Hypocalcemia and Hypercalcemia |
|
|
231 | (4) |
|
|
|
|
|
|
235 | (3) |
|
|
|
|
|
|
|
|
|
|
238 | (3) |
|
|
|
|
|
|
|
|
Index |
|
241 | |